IL244237B
Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
60 members in 38 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 201361869510 | United States of America | P | |
| 201361907749 | United States of America | P | |
| 13198784 | European Patent Office (EPO) | A | |
| 201461990475 | United States of America | P | |
| 2014051790 | United States of America | W |
Members60
| Document | Office | Kind | |
|---|---|---|---|
| EP2839842A1 | European Patent Office (EPO) | A1 | |
| CA2920116A1 | Canada | A1 | |
| WO2015026892A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201542593A | Taiwan Province of China | A | |
| AP2016009029A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| AR097405A1 | Argentina | A1 | |
| AU2014308905A1 | Australia | A1 | |
| SG11201601317UA | Singapore | A | |
| IL244237A0 | Israel | A0 | |
| IL244237D0 | Israel | D0 | |
| KR20160045134A | Republic of Korea | A | |
| PH12016500311A1 | Philippines | A1 | |
| PH12016500311B1 | Philippines | B1 | |
| PE20160509A1 | Peru | A1 | |
| MX2016002260A | Mexico | A | |
| EP3035965A1 | European Patent Office (EPO) | A1 | |
| CR20160108A | Costa Rica | A | |
| US2016200827A1 | United States of America | A1 | |
| CN105873607A | China | A | |
| EA201690443A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CL2016000362A1 | Chile | A1 | |
| JP2017504577A | Japan | A | |
| EP3035965A4 | European Patent Office (EPO) | A4 | |
| TN2016000046A1 | Tunisia | A1 | |
| ZA201600653B | South Africa | B | |
| HK1225999A | Hong Kong, China | A | |
| HK1225999A1 | Hong Kong, China | A1 | |
| US9822181B2 | United States of America | B2 | |
| BR112016003417A2 | Brazil | A2 | |
| US2018094072A1 | United States of America | A1 | |
| AU2014308905B2 | Australia | B2 | |
| JP6524087B2 | Japan | B2 | |
| UA119539C2 | Ukraine | C2 | |
| TWI669310B | Taiwan Province of China | B | |
| GEP20197053B | Georgia | B | |
| EA034142B1 | Eurasian Patent Organization (EAPO) | B1 | |
| CN105873607B | China | B | |
| MX373374B | Mexico | B | |
| IL244237A | Israel | A | |
| IL244237BThis record | Israel | B | |
| US10787521B2 | United States of America | B2 | |
| EP3035965B1 | European Patent Office (EPO) | B1 | |
| DK3035965T3 | Denmark | T3 | |
| US2021047426A1 | United States of America | A1 | |
| PT3035965T | Portugal | T | |
| RS61522B1 | Serbia | B1 | |
| LT3035965T | Lithuania | T | |
| HRP20210215T1 | Croatia | T1 | |
| EP3808776A1 | European Patent Office (EPO) | A1 | |
| SMT202100123T1 | San Marino | T1 | |
| PL3035965T3 | Poland | T3 | |
| PL3035965T4 | Poland | T4 | |
| SI3035965T1 | Slovenia | T1 | |
| KR102287523B1 | Republic of Korea | B1 | |
| HUE054315T2 | Hungary | T2 | |
| SA516370567B1 | Saudi Arabia | B1 | |
| SA8650B1 | Saudi Arabia | B1 | |
| NZ716914A | New Zealand | A | |
| ES2860973T3 | Spain | T3 | |
| CY1123940T1 | Cyprus | T1 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication
- 244237
- Application
- 244237
Titles2
- English
- Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof
- Hebrew
- דיאבודים ביספציפים מונווולנטים בעלי יכולת קישור ל cd123 ו cd3 ושימושים שלהם
Classification
- CPC, 21
- C07K16/2809
- C07K16/2896
- A61P11/06
- A61K2039/505
- C07K16/2866
- C07K2317/31
- C07K2317/33
- C07K2317/56
- C07K2317/626
- C07K2317/73
- C07K2317/92
- C07K2319/30
- C07K2319/31
- A61P17/02
- A61P19/02
- A61P29/00
- A61P35/00
- A61P35/02
- A61P35/04
- A61P37/00
- A61P37/08